US Stock MarketDetailed Quotes

MBX Biosciences (MBX)

Watchlist
  • 41.280
  • +0.370+0.90%
Trading Jan 16 14:18 ET
1.85BMarket Cap-22.93P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

MBX Biosciences (MBX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-46.86%-21.54M
-31.38%-17.43M
-111.75%-22.68M
-71.00%-54.68M
-43.88%-16.04M
-89.80%-14.66M
-13.27M
-10.71M
-38.30%-31.98M
-11.15M
Net income from continuing operations
-19.16%-21.62M
-22.41%-19.41M
-93.56%-23.88M
-90.16%-61.92M
-76.25%-15.59M
-78.51%-18.14M
---15.86M
---12.34M
-24.60%-32.56M
---8.84M
Operating gains losses
----
----
----
----
----
----
----
----
-92.90%69K
----
Depreciation and amortization
-33.33%50K
-3.17%61K
60.42%77K
55.41%244K
41.46%58K
87.50%75K
--63K
--48K
180.36%157K
--41K
Other non cash items
18.52%32K
48.15%40K
16.00%29K
11.58%106K
8.00%27K
12.50%27K
--27K
--25K
-77.16%95K
--25K
Change In working capital
-154.53%-1.51M
-54.53%918K
38.25%600K
725.44%4.6M
78.05%-627K
54.63%2.77M
--2.02M
--434K
-156.98%-735K
---2.86M
-Change in prepaid assets
-171.53%-1.55M
31.35%-795K
303.92%1.65M
-124.26%-2.35M
22.16%-1.03M
-562.60%-569K
---1.16M
--408K
-32.36%-1.05M
---1.32M
-Change in payables and accrued expense
-100.12%-4K
-45.32%1.76M
-1,696.83%-1.01M
1,453.17%7.1M
129.64%442K
98.24%3.38M
--3.22M
--63K
-78.47%457K
---1.49M
-Change in other current assets
--65K
----
----
--0
--0
--0
----
----
80.95%-8K
----
-Change in other current liabilities
28.95%-27K
1,471.05%521K
-13.51%-42K
-11.68%-153K
-14.29%-40K
-8.57%-38K
---38K
---37K
---137K
---35K
Cash from discontinued investing activities
Operating cash flow
-46.86%-21.54M
-31.38%-17.43M
-111.75%-22.68M
-71.00%-54.68M
-43.88%-16.04M
-89.80%-14.66M
---13.27M
---10.71M
-38.30%-31.98M
---11.15M
Investing cash flow
Cash flow from continuing investing activities
116.92%17.06M
429.31%25.99M
-79.09%3.23M
-419.27%-160.6M
-132.59%-67.35M
-441.73%-100.79M
-7.89M
15.43M
-171.03%-30.93M
-28.96M
Net PPE purchase and sale
-600.00%-399K
-56.42%-707K
89.01%-30K
-577.52%-874K
-67.27%-92K
-159.09%-57K
---452K
---273K
70.75%-129K
---55K
Net investment purchase and sale
117.33%17.46M
458.83%26.69M
-79.26%3.26M
-418.61%-159.72M
-132.71%-67.25M
-442.06%-100.73M
---7.44M
--15.7M
-180.75%-30.8M
---28.9M
Cash from discontinued investing activities
Investing cash flow
116.92%17.06M
429.31%25.99M
-79.09%3.23M
-419.27%-160.6M
-132.59%-67.35M
-441.73%-100.79M
---7.89M
--15.43M
-171.03%-30.93M
---28.96M
Financing cash flow
Cash flow from continuing financing activities
-20.35%187.82M
175.30%1.33M
-97.81%4K
238.21%234.1M
-794.74%-132K
244.27%235.81M
-1.76M
183K
50.27%69.22M
19K
Net common stock issuance
----
----
----
--174.54M
--0
----
----
----
--0
--0
Net preferred stock issuance
----
----
----
-7.31%63.5M
--0
----
----
----
87.74%68.51M
--0
Proceeds from stock option exercised by employees
519.35%130K
2,552.00%1.33M
-97.88%4K
-45.47%403K
926.32%195K
-282.35%-31K
--50K
--189K
2,363.33%739K
--19K
Net other financing activities
----
----
----
-14,370.00%-4.34M
---327K
---2.2M
---1.81M
---6K
93.45%-30K
--0
Cash from discontinued financing activities
Financing cash flow
-20.35%187.82M
175.30%1.33M
-97.81%4K
238.21%234.1M
-794.74%-132K
244.27%235.81M
---1.76M
--183K
50.27%69.22M
--19K
Net cash flow
Beginning cash position
218.17%39.78M
-15.59%29.9M
61.68%49.35M
26.08%30.52M
88.18%132.87M
-56.04%12.5M
--35.43M
--30.52M
90.93%24.21M
--70.61M
Current changes in cash
52.33%183.34M
143.09%9.88M
-496.74%-19.45M
198.24%18.83M
-108.36%-83.51M
185.45%120.36M
---22.92M
--4.9M
-45.25%6.31M
---40.08M
End cash Position
67.93%223.13M
218.17%39.78M
-15.59%29.9M
61.68%49.35M
61.68%49.35M
88.18%132.87M
--12.5M
--35.43M
26.08%30.52M
--30.52M
Free cash flow
-49.00%-21.94M
-32.20%-18.14M
-106.76%-22.71M
-73.03%-55.56M
-44.00%-16.13M
-90.00%-14.72M
---13.72M
---10.98M
-36.26%-32.11M
---11.2M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -46.86%-21.54M-31.38%-17.43M-111.75%-22.68M-71.00%-54.68M-43.88%-16.04M-89.80%-14.66M-13.27M-10.71M-38.30%-31.98M-11.15M
Net income from continuing operations -19.16%-21.62M-22.41%-19.41M-93.56%-23.88M-90.16%-61.92M-76.25%-15.59M-78.51%-18.14M---15.86M---12.34M-24.60%-32.56M---8.84M
Operating gains losses ---------------------------------92.90%69K----
Depreciation and amortization -33.33%50K-3.17%61K60.42%77K55.41%244K41.46%58K87.50%75K--63K--48K180.36%157K--41K
Other non cash items 18.52%32K48.15%40K16.00%29K11.58%106K8.00%27K12.50%27K--27K--25K-77.16%95K--25K
Change In working capital -154.53%-1.51M-54.53%918K38.25%600K725.44%4.6M78.05%-627K54.63%2.77M--2.02M--434K-156.98%-735K---2.86M
-Change in prepaid assets -171.53%-1.55M31.35%-795K303.92%1.65M-124.26%-2.35M22.16%-1.03M-562.60%-569K---1.16M--408K-32.36%-1.05M---1.32M
-Change in payables and accrued expense -100.12%-4K-45.32%1.76M-1,696.83%-1.01M1,453.17%7.1M129.64%442K98.24%3.38M--3.22M--63K-78.47%457K---1.49M
-Change in other current assets --65K----------0--0--0--------80.95%-8K----
-Change in other current liabilities 28.95%-27K1,471.05%521K-13.51%-42K-11.68%-153K-14.29%-40K-8.57%-38K---38K---37K---137K---35K
Cash from discontinued investing activities
Operating cash flow -46.86%-21.54M-31.38%-17.43M-111.75%-22.68M-71.00%-54.68M-43.88%-16.04M-89.80%-14.66M---13.27M---10.71M-38.30%-31.98M---11.15M
Investing cash flow
Cash flow from continuing investing activities 116.92%17.06M429.31%25.99M-79.09%3.23M-419.27%-160.6M-132.59%-67.35M-441.73%-100.79M-7.89M15.43M-171.03%-30.93M-28.96M
Net PPE purchase and sale -600.00%-399K-56.42%-707K89.01%-30K-577.52%-874K-67.27%-92K-159.09%-57K---452K---273K70.75%-129K---55K
Net investment purchase and sale 117.33%17.46M458.83%26.69M-79.26%3.26M-418.61%-159.72M-132.71%-67.25M-442.06%-100.73M---7.44M--15.7M-180.75%-30.8M---28.9M
Cash from discontinued investing activities
Investing cash flow 116.92%17.06M429.31%25.99M-79.09%3.23M-419.27%-160.6M-132.59%-67.35M-441.73%-100.79M---7.89M--15.43M-171.03%-30.93M---28.96M
Financing cash flow
Cash flow from continuing financing activities -20.35%187.82M175.30%1.33M-97.81%4K238.21%234.1M-794.74%-132K244.27%235.81M-1.76M183K50.27%69.22M19K
Net common stock issuance --------------174.54M--0--------------0--0
Net preferred stock issuance -------------7.31%63.5M--0------------87.74%68.51M--0
Proceeds from stock option exercised by employees 519.35%130K2,552.00%1.33M-97.88%4K-45.47%403K926.32%195K-282.35%-31K--50K--189K2,363.33%739K--19K
Net other financing activities -------------14,370.00%-4.34M---327K---2.2M---1.81M---6K93.45%-30K--0
Cash from discontinued financing activities
Financing cash flow -20.35%187.82M175.30%1.33M-97.81%4K238.21%234.1M-794.74%-132K244.27%235.81M---1.76M--183K50.27%69.22M--19K
Net cash flow
Beginning cash position 218.17%39.78M-15.59%29.9M61.68%49.35M26.08%30.52M88.18%132.87M-56.04%12.5M--35.43M--30.52M90.93%24.21M--70.61M
Current changes in cash 52.33%183.34M143.09%9.88M-496.74%-19.45M198.24%18.83M-108.36%-83.51M185.45%120.36M---22.92M--4.9M-45.25%6.31M---40.08M
End cash Position 67.93%223.13M218.17%39.78M-15.59%29.9M61.68%49.35M61.68%49.35M88.18%132.87M--12.5M--35.43M26.08%30.52M--30.52M
Free cash flow -49.00%-21.94M-32.20%-18.14M-106.76%-22.71M-73.03%-55.56M-44.00%-16.13M-90.00%-14.72M---13.72M---10.98M-36.26%-32.11M---11.2M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.22%
Sample Name
Sample Code
 +3.69%
Sample Name
Sample Code
 +2.86%
4
Clean Energy Fuels
CLNE
+1.59%
5
Block
XYZ
+1.25%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.46%
Sample Name
Sample Code
 +10.29%
Sample Name
Sample Code
 +9.47%
4
Kingsoft Cloud
KC
+6.94%
5
United Microelectronics
UMC
+6.31%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -